Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femoroacetabular Impingement Syndrome

NCT07472400 · tracked via the Priya Life Science Belgium tracker
Phase
Observational
Started
2026-03-01
Last updated
2026-05-05

Condition(s) studied

Femoroacetabular Impingement SyndromeHealthy Participants

Study summary

The aim of this study is to identify the factors associated with successful rehabilitation following hip arthroscopy for femoroacetabular impingement syndrome and to highlight any persistent functional deficits at different key stages of rehabilitation. This is a controlled multi-observational study. The pathological hip of patients will be compared to their second healthy hip as well as to a healthy control group.

Assessments of mobility, strength, functional tests, and questionnaire submissions will take place before the intervention and 3 and 6 months after the intervention.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Subjects with femoroacetabular impingement syndrome, with corresponding clinical symptoms and signs, as well as validation by imaging * Subjects who have already consulted a surgeon specializing in hip arthroscopic surgery and whose surgery is planned to treat femoroacetabular impingement syndrome * Subjects aged between 18 and 40 Exclusion Criteria: * History of rheumatic disease, dysplasia or pediatric disease affecting the hip (Legg-Calvé; superior femoral epiphysiolysis) * Subject who has already undergone surgery on the hip joint * Subjects with a history of injury to the muscles involved in the assessments within the last year

Primary outcome measure(s)

  • Muscle strength in Nm — Pre-intervention, at 3 months and 6 months post-intervention
    Muscular strength is measured using a fixed dynamometer
  • Hip mobility in degree — Pre-intervention, at 3 months and 6 months post-intervention
    Hip mobility is measured using an electronic goniometer
  • Functional results on the Y Balance Test — Pre-intervention, at 3 months and 6 months post-intervention
    The functional results of the Y balance test will be measured using the composite score.
  • Functional results in the single-leg squat test — Pre-intervention, at 3 months and 6 months post-intervention
    The functional results of the single-leg squat test will be measured using the SIngle-leg squat Movement Performance scaLe for Individuals with FemoroAcetabular Impingement syndrome (SIMPLAI-FAI). The score on this scale ranges from 0 to 8. A higher score indicates a better functional outcome.
  • Measurements of patient-reported outcomes using the Hip-Return to Sport After Injury Scale (HIP-RSI) — Pre-intervention, at 3 months and 6 months post-intervention
    Analysis of scores obtained on the HIP-RSI questionnaire. This questionnaire assesses psychological readiness to resume sports activities following hip surgery. It consists of six items, and the final score ranges from 0 to 100. A higher score indicates greater psychological readiness to return to sports activities.
  • Measurements of patient-reported outcomes using the International Hip Outcome Tool-12 (iHot-12) questionnaire — Pre-intervention, at 3 months and 6 months post-intervention
    Analysis of scores obtained on the iHot-12 questionnaire. This questionnaire assesses the quality of life of young, active patients suffering from hip problems. It consists of 12 items and the final score ranges from 0 to 100. A score of 100 indicates full function and no symptoms, whereas a score of zero signifies maximum limitations and extreme symptoms.

Trial sites (1)

FacilityCityRegionStatus
Blanc Gravier sports centers Sart Tilman Liège Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07472400 on ClinicalTrials.gov ↗ ← All trials in Belgium